Study of Effectiveness of Mexyn-A (Mexyn-A)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00568204
Recruitment Status : Completed
First Posted : December 5, 2007
Last Update Posted : October 17, 2013
Information provided by:
Evangelical Synod Medical Centre

Brief Summary:
Atomised Methoxymethane-in-Aqua (MEXYN-A) a new topical self-chilled, non-steroidal, non-flammable, pressurised spray which embodies in one simultaneous application, most of the currently recognised and effective chemical, mechanical and thermal anti-pruritic therapies and hydrotherapy.

Condition or disease Intervention/treatment Phase
Pruritus Device: Mexyn-A Not Applicable

Detailed Description:
The primary clinical endpoint was to establish MEXYN-A efficacy and safety in abolishing or reducing pruritus related to cutaneous diseases, insect bites and poison ivy, within few seconds of the application. The secondary endpoint was to measure the itch free period as a result of the new intervention.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 279 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Proof of Concept of MEXYN-A
Study Start Date : March 2002
Actual Study Completion Date : September 2005

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Itching

Arm Intervention/treatment
Experimental: 1
Device: Mexyn-A
Atomised topical self-chilled pressurised spray
Other Name: Clearitch, Itcharret, itchclear, Magicool-Plus

Primary Outcome Measures :
  1. Treating Pruritus [ Time Frame: three days ]

Secondary Outcome Measures :
  1. measuring itch-free period after applying the new treatment, effect on sleep disturbance [ Time Frame: three days ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   5 Years to 80 Years   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Patients suffering from severe itching due to : Atopic Dermatitis, contact dermatitis, psoriasis, urticaria, xerosis, prickly heat, genital pruritus, chicken pox, aquagenic pruritus, lichen planus, poison ivey, insect bites.
  • Past experience with the use of at least one conventional medication for pruritus or conventional medication for the same disorder patients suffered.

Exclusion Criteria:

  • Patients who have taken any anti-pruritic drug during the month prior to participation.
  • Patients who have taken drugs for any reason for 2 days prior to participating in the study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00568204

Evangelical Synod Medical Centre
Cairo, Egypt, 11111
Sponsors and Collaborators
Evangelical Synod Medical Centre
Principal Investigator: Ihab Akhnoukh Evangelical Synod Medical Centre
Study Director: Ashraf Khella Harpur Memorial Hospital

Responsible Party: Dr Ihab Akhnoukh M.D., Evangelical Synod Medical Centre Identifier: NCT00568204     History of Changes
Other Study ID Numbers: EvangelicalSynodMC
First Posted: December 5, 2007    Key Record Dates
Last Update Posted: October 17, 2013
Last Verified: October 2013

Keywords provided by Evangelical Synod Medical Centre:
pruritus, itching, mexyn-a, clearitch, magicool-plus

Additional relevant MeSH terms:
Skin Diseases
Skin Manifestations
Signs and Symptoms